Dyne Therapeutics, Inc. (DYN)

9.27 -0.05 (-0.54%) At close: 04:00PM EDT

Dyne Therapeutics, Inc.

1560 Trapelo Road
Waltham, MA 02451
United States
781 786 8230
https://www.dyne-tx.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 134

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Joshua T. Brumm	CEO, Pres & Director	946.5k	N/A	1978
Ms. Susanna Gatti High M.B.A.	Chief Operating Officer	655.5k	N/A	1968
Dr. Oxana Beskrovnaya Ph.D.	Chief Scientific Officer	631.08k	N/A	1962
Dr. Romesh Subramanian Ph.D.	Co-Founder & Advisor	N/A	N/A	1965
Mr. Richard William Scalzo M.B.A.	Sr. VP and Head of Fin. & Admin.	N/A	N/A	1987
Mr. John Najim M.B.A.	Chief Technical Officer	N/A	N/A	N/A
Ms. Amy Reilly	Sr. VP and Head of Corp. Communications & Investor Relations	N/A	N/A	1974
Mr. Daniel Wilson	Sr. VP & Head of Legal	N/A	N/A	1972
Ms. Kate Mitchell	VP & Head of HR	N/A	N/A	N/A
Ms. Debra Feldman	Chief Regulatory Affairs Officer	N/A	N/A	1971

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Dyne Therapeutics, Inc.’s ISS Governance QualityScore as of September 1, 2023 is 9. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.